Page 3 - Evidence Development News Today

2023 UK Annual Report 2023 UK Annual Report DEFINITIONS In this LivaNova PLC 2023 UK Annual Report, the...

Highmark includes Nerivio Remote Electrical Neuromodulation (REN) wearable in its commercial coverage policy for migraine treatment.

/PRNewswire/ -- Theranica, a pioneering prescribed digital therapeutics company specializing in neuromodulation devices for migraine and other idiopathic pain...

COVID-19 proved a galvanizing event for the use of real-world data. Has its momentum endured?

Congress has been closely following both the Trump and Biden administration's proposals for Medicare coverage for Food and Drug Administration (FDA)-designated breakthrough devices.

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) announced its proposed “Transitional Coverage for Technologies” (TCET) pathway—the Biden administration’s highly...

Committee chair expresses concern about agency's lack of a 'predictable coverage pathway'

On June 27, 2023, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) issued a “Notice with Comment Period” (“Notice”) describing a new process for providing expedited...

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) released a long-awaited procedural notice with comment period (CMS-3421-NC) that outlines a proposed Transitional Coverage...

The goal is to make providers more sensitive to drug costs, says MedPAC's director